Resources & Information

Feb 25 2020

New position statement: Use of innovative treatments

Comments:   0 comments  Print Friendly Version  |   Share this item
NCMB outlined its expectations for licensees who may wish to consider or recommend new and innovative treatments for patients in a new position statement entitled, Licensee use of new or innovative treatment. Some key principles include:

* Avoiding overpromising or exaggerating benefits of the treatment;
* Balancing the need to honor patient autonomy against the need to protect patients from risks of novel treatments;
* Ensuring that treatment decisions are always made in the best interest of patients.

NCMB is grateful to all who provided feedback during the development of the new position statement.

Read the full text of the new position.

 No Comments on this article

 Post a comment on this article
Please do not include links to external websites in your comment. Please limit comments to no more than 300 words. The NCMB reserves the right to edit comments to meet the length limit. Abusive or profane remarks and personal attacks will not be published. The editor will make every effort to review and post comments in a timely fashion.